Janssen Vaccines & Prevention B.V.
Leiden, Zuid-Holland, Netherlands
Purpose
to assess safety and tolerability of different vaccine regimens with Ad26.Mos4.HIV, Ad26.Mos.HIV and Clade C gp140 and immunogenicity between the different vaccine regimens with Ad26.Mos4.HIV, Ad26.Mos.HIV and Clade C gp140
Division
Global Health
Date
October 2016
Region Served
AFRICA
Committed amount
$4,472,467
Grant topic
HIV
Duration (months)
75
Grantee location
Leiden, Zuid-Holland, Netherlands
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.